Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BERYL DRUGS vs SAMRAT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BERYL DRUGS SAMRAT PHARMA BERYL DRUGS/
SAMRAT PHARMA
 
P/E (TTM) x 49.8 21.7 229.1% View Chart
P/BV x 1.9 2.2 86.7% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 BERYL DRUGS   SAMRAT PHARMA
EQUITY SHARE DATA
    BERYL DRUGS
Mar-24
SAMRAT PHARMA
Mar-24
BERYL DRUGS/
SAMRAT PHARMA
5-Yr Chart
Click to enlarge
High Rs45604 7.4%   
Low Rs12320 3.6%   
Sales per share (Unadj.) Rs52.7911.3 5.8%  
Earnings per share (Unadj.) Rs1.57.0 21.7%  
Cash flow per share (Unadj.) Rs3.99.1 42.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Avg Dividend yield %00.2 0.0%  
Book value per share (Unadj.) Rs17.6210.3 8.4%  
Shares outstanding (eoy) m5.073.09 164.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.50.5 105.9%   
Avg P/E ratio x18.766.0 28.3%  
P/CF ratio (eoy) x7.350.8 14.3%  
Price / Book Value ratio x1.62.2 73.3%  
Dividend payout %014.3 0.0%   
Avg Mkt Cap Rs m1441,428 10.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1711 154.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2672,816 9.5%  
Other income Rs m514 34.7%   
Total revenues Rs m2722,830 9.6%   
Gross profit Rs m2225 89.2%  
Depreciation Rs m126 185.6%   
Interest Rs m57 69.0%   
Profit before tax Rs m1025 40.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24 67.3%   
Profit after tax Rs m822 35.6%  
Gross profit margin %8.20.9 939.6%  
Effective tax rate %23.914.2 168.2%   
Net profit margin %2.90.8 374.4%  
BALANCE SHEET DATA
Current assets Rs m1051,026 10.3%   
Current liabilities Rs m61564 10.8%   
Net working cap to sales %16.716.4 101.9%  
Current ratio x1.71.8 95.4%  
Inventory Days Days1411 124.0%  
Debtors Days Days1,036898 115.3%  
Net fixed assets Rs m72192 37.4%   
Share capital Rs m5131 164.9%   
"Free" reserves Rs m38619 6.2%   
Net worth Rs m89650 13.7%   
Long term debt Rs m240-   
Total assets Rs m1771,217 14.5%  
Interest coverage x3.14.7 67.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x1.52.3 65.3%   
Return on assets %7.02.3 299.7%  
Return on equity %8.63.3 258.9%  
Return on capital %13.14.9 265.4%  
Exports to sales %02.0 0.0%   
Imports to sales %083.5 0.0%   
Exports (fob) Rs mNA58 0.0%   
Imports (cif) Rs mNA2,350 0.0%   
Fx inflow Rs m058 0.0%   
Fx outflow Rs m02,350 0.0%   
Net fx Rs m0-2,293 -0.0%   
CASH FLOW
From Operations Rs m894 8.7%  
From Investments Rs m-11-4 266.5%  
From Financial Activity Rs m1-112 -0.9%  
Net Cashflow Rs m-2-22 7.2%  

Share Holding

Indian Promoters % 26.4 49.0 53.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.2 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 73.6 51.1 144.2%  
Shareholders   7,364 6,984 105.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BERYL DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on BERYL DRUGS vs SAMRAT PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BERYL DRUGS vs SAMRAT PHARMA Share Price Performance

Period BERYL DRUGS SAMRAT PHARMA S&P BSE HEALTHCARE
1-Day 0.76% 3.19% 0.56%
1-Month -4.35% -1.46% 0.88%
1-Year 52.71% 23.96% 45.71%
3-Year CAGR 47.85% 24.29% 19.49%
5-Year CAGR 43.78% 36.38% 26.03%

* Compound Annual Growth Rate

Here are more details on the BERYL DRUGS share price and the SAMRAT PHARMA share price.

Moving on to shareholding structures...

The promoters of BERYL DRUGS hold a 26.4% stake in the company. In case of SAMRAT PHARMA the stake stands at 49.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BERYL DRUGS and the shareholding pattern of SAMRAT PHARMA.

Finally, a word on dividends...

In the most recent financial year, BERYL DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

SAMRAT PHARMA paid Rs 1.0, and its dividend payout ratio stood at 14.3%.

You may visit here to review the dividend history of BERYL DRUGS, and the dividend history of SAMRAT PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.